Benitec Biopharma Inc. (BNTC) |
| 12.99 -0.43 (-3.2%) 07-13 16:00 |
| Open: | 13.28 |
| High: | 13.435 |
| Low: | 12.82 |
| Volume: | 85,451 |
| Market Cap: | 341(M) |
| PE Ratio: | -11.39 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 16.74 |
| Resistance 1: | 14.33 |
| Pivot price: | 13.08 |
| Support 1: | 11.65 |
| Support 2: | 10.00 |
| 52w High: | 16.76 |
| 52w Low: | 9.85 |
Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.
| EPS | -0.930 |
| Book Value | 5.340 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -19.9 |
| Return on Equity (ttm) | -29.6 |
Fri, 10 Jul 2026
BNTC Q2 2026 Earnings: Narrowed Loss Beats Expectations Amid Pipeline Progress - Earnings Trend Analysis - dars.gov.et
Sat, 04 Jul 2026
Price to sales forward of Benitec Biopharma Inc. – NASDAQ:BNTC - TradingView
Thu, 02 Jul 2026
BNTC - Benitec Biopharma Inc Latest SEC Filings - Finviz
Tue, 30 Jun 2026
Benitec Biopharma (NASDAQ: BNTC) director gifts 51,813 shares to donor-advised fund - Stock Titan
Mon, 29 Jun 2026
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 2000 Value Benchmark - marketscreener.com
Mon, 29 Jun 2026
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Microcap Value Benchmark Index - marketscreener.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |